HomeCompareWXIBF vs PLD

WXIBF vs PLD: Dividend Comparison 2026

WXIBF yields 43.48% · PLD yields 3.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PLD wins by $5.63M in total portfolio value· pulled ahead in Year 8
10 years
WXIBF
WXIBF
● Live price
43.48%
Share price
$4.60
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$279.7K
Annual income
$50,636.72
Full WXIBF calculator →
PLD
PLD
● Live price
3.10%
Share price
$132.18
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.91M
Annual income
$4,750,725.19
Full PLD calculator →

Portfolio growth — WXIBF vs PLD

📍 PLD pulled ahead of the other in Year 8

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodWXIBFPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, WXIBF + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
WXIBF pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

WXIBF
Annual income on $10K today (after 15% tax)
$3,695.65/yr
After 10yr DRIP, annual income (after tax)
$43,041.21/yr
PLD
Annual income on $10K today (after 15% tax)
$263.66/yr
After 10yr DRIP, annual income (after tax)
$4,038,116.41/yr
At 15% tax rate, PLD beats the other by $3,995,075.20/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of WXIBF + PLD for your $10,000?

WXIBF: 50%PLD: 50%
100% PLD50/50100% WXIBF
Portfolio after 10yr
$3.09M
Annual income
$2,400,680.95/yr
Blended yield
77.59%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

WXIBF
No analyst data
Altman Z
10.0
Piotroski
9/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+2.9% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

WXIBF buys
0
PLD buys
0
No recent congressional trades found for WXIBF or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricWXIBFPLD
Forward yield43.48%3.10%
Annual dividend / share$2.00$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$279.7K$5.91M
Annual income after 10y$50,636.72$4,750,725.19
Total dividends collected$215.5K$5.78M
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: WXIBF vs PLD ($10,000, DRIP)

YearWXIBF PortfolioWXIBF Income/yrPLD PortfolioPLD Income/yrGap
1$15,048$4,347.83$11,241$540.96+$3.8KWXIBF
2$22,216$6,114.52$13,019$991.13+$9.2KWXIBF
3$32,207$8,436.54$15,801$1,870.97+$16.4KWXIBF
4$45,893$11,430.77$20,609$3,701.21+$25.3KWXIBF
5$64,327$15,222.29$29,919$7,867.97+$34.4KWXIBF
6$88,771$19,941.10$50,631$18,617.74+$38.1KWXIBF
7$120,704$25,718.32$105,528$51,352.20+$15.2KWXIBF
8← crossover$161,835$32,681.83$287,364$174,449.42$125.5KPLD
9$214,115$40,951.88$1,081,760$774,280.77$867.6KPLD
10$279,740$50,636.72$5,908,209$4,750,725.19$5.63MPLD

WXIBF vs PLD: Complete Analysis 2026

WXIBFStock

WuXi Biologics (Cayman) Inc. provides end-to-end solutions and services for biologics discovery, development and manufacturing in the People's Republic of China, North America, Europe, and internationally. The company also engages in the provision of consultation services in relation to the biopharmaceutical technology, international sales contracting services, testing and development of testing technologies, sales and marketing services, and biologics clinical and manufacturing services; production and sale of medicals; vaccine CDMO and related business; and material supplier activities. WuXi Biologics (Cayman) Inc. has strategic partnership with ImmuneOncia Therapeutics, Legochem Biosciences Inc, Worg Pharma, OncoC4, and Exelixis Inc. The company was incorporated in 2014 and is headquartered in Wuxi, China.

Full WXIBF Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this WXIBF vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

WXIBF vs SCHDWXIBF vs JEPIWXIBF vs OWXIBF vs KOWXIBF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.